{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4208"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4208","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"To decipher genomic evolution of dengue virus and to probe the activation mechanism of a HER2 directed chimeric antigen receptor toward computer aided drug design (CADD)","abstract":"This study encompasses three significant chapters focusing on diverse yet interconnected aspects of pharmaceutical research. Chapter 1 delves into the complexities of drug development, emphasizing the challenges and the pressing need for advanced technologies to streamline the process. Computational methods like Computer-Aided Drug Design (CADD) extend their scope beyond small molecules, aiding in the design of intricate biomolecules vital for biomedical advancements, especially in immunotherapy. Chapter 2 introduces the Near-Neutral Balanced Selectionist Theory (NNBST) validated through analysis of Dengue virus evolution. The unique features observed align with NNBST, surpassing existing theories. This approach offers a deeper understanding of viral evolution dynamics, identifying conserved segments critical for vaccine development and shedding light on potential drug targets, amplifying the battle against Dengue. Finally, Chapter 3 focuses on molecular dynamics simulations of a novel anti-HER2 Chimeric Antigen Receptor (CAR) for HER2-positive cancer treatment. The proposed Binding Induced Domain Dynamics Switch (BIDDS) unveils a new signal transduction mechanism, revolutionizing the understanding of CAR activation. This breakthrough not only challenges existing models but also opens avenues for broader applications in receptor-based therapies. These chapters collectively represent a multidisciplinary approach merging computational techniques, evolutionary biology, and molecular dynamics simulations, promising significant contributions to drug development, viral evolution understanding, and therapeutic advancements in cancer treatment.","abstract_html":"This study encompasses three significant chapters focusing on diverse yet interconnected aspects of pharmaceutical research. Chapter 1 delves into the complexities of drug development, emphasizing the challenges and the pressing need for advanced technologies to streamline the process. Computational methods like Computer-Aided Drug Design (CADD) extend their scope beyond small molecules, aiding in the design of intricate biomolecules vital for biomedical advancements, especially in immunotherapy. Chapter 2 introduces the Near-Neutral Balanced Selectionist Theory (NNBST) validated through analysis of Dengue virus evolution. The unique features observed align with NNBST, surpassing existing theories. This approach offers a deeper understanding of viral evolution dynamics, identifying conserved segments critical for vaccine development and shedding light on potential drug targets, amplifying the battle against Dengue. Finally, Chapter 3 focuses on molecular dynamics simulations of a novel anti-HER2 Chimeric Antigen Receptor (CAR) for HER2-positive cancer treatment. The proposed Binding Induced Domain Dynamics Switch (BIDDS) unveils a new signal transduction mechanism, revolutionizing the understanding of CAR activation. This breakthrough not only challenges existing models but also opens avenues for broader applications in receptor-based therapies. These chapters collectively represent a multidisciplinary approach merging computational techniques, evolutionary biology, and molecular dynamics simulations, promising significant contributions to drug development, viral evolution understanding, and therapeutic advancements in cancer treatment.","abstract_has_math":false,"creators":["Hryb, Mariya"],"institution":null,"degree_name":"Master of Science (M.S.) in Pharmaceutical Science","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zhiwei Liu, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:40Z","subjects":["computer-aided drug design","viral evolution dynamics","molecular dynamics simulation","near-neutral balanced selectionist theory","anti-HER2 chimeric antigen receptor","HER-2 positive cancer treatment","Drugs-- Design","Cancer--Treatment","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3202","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3202","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4208","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zhiwei Liu, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Hryb, Mariya"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-04-16T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-04-16T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.) in Pharmaceutical Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["computer-aided drug design","viral evolution dynamics","molecular dynamics simulation","near-neutral balanced selectionist theory","anti-HER2 chimeric antigen receptor","HER-2 positive cancer treatment","Drugs-- Design","Cancer--Treatment","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3202"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This study encompasses three significant chapters focusing on diverse yet interconnected aspects of pharmaceutical research. Chapter 1 delves into the complexities of drug development, emphasizing the challenges and the pressing need for advanced technologies to streamline the process. Computational methods like Computer-Aided Drug Design (CADD) extend their scope beyond small molecules, aiding in the design of intricate biomolecules vital for biomedical advancements, especially in immunotherapy. Chapter 2 introduces the Near-Neutral Balanced Selectionist Theory (NNBST) validated through analysis of Dengue virus evolution. The unique features observed align with NNBST, surpassing existing theories. This approach offers a deeper understanding of viral evolution dynamics, identifying conserved segments critical for vaccine development and shedding light on potential drug targets, amplifying the battle against Dengue. Finally, Chapter 3 focuses on molecular dynamics simulations of a novel anti-HER2 Chimeric Antigen Receptor (CAR) for HER2-positive cancer treatment. The proposed Binding Induced Domain Dynamics Switch (BIDDS) unveils a new signal transduction mechanism, revolutionizing the understanding of CAR activation. This breakthrough not only challenges existing models but also opens avenues for broader applications in receptor-based therapies. These chapters collectively represent a multidisciplinary approach merging computational techniques, evolutionary biology, and molecular dynamics simulations, promising significant contributions to drug development, viral evolution understanding, and therapeutic advancements in cancer treatment."]},{"key":"dc:title","label":"Title","values":["To decipher genomic evolution of dengue virus and to probe the activation mechanism of a HER2 directed chimeric antigen receptor toward computer aided drug design (CADD)"]}]}],"canonical_facts":{"dc:contributor":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zhiwei Liu, Ph.D."],"dc:creator":["Hryb, Mariya"],"dc:date.available":["2024-04-16T07:00:00Z"],"dc:date.created":["2024-04-16T07:00:00Z"],"dc:description.abstract":["This study encompasses three significant chapters focusing on diverse yet interconnected aspects of pharmaceutical research. Chapter 1 delves into the complexities of drug development, emphasizing the challenges and the pressing need for advanced technologies to streamline the process. Computational methods like Computer-Aided Drug Design (CADD) extend their scope beyond small molecules, aiding in the design of intricate biomolecules vital for biomedical advancements, especially in immunotherapy. Chapter 2 introduces the Near-Neutral Balanced Selectionist Theory (NNBST) validated through analysis of Dengue virus evolution. The unique features observed align with NNBST, surpassing existing theories. This approach offers a deeper understanding of viral evolution dynamics, identifying conserved segments critical for vaccine development and shedding light on potential drug targets, amplifying the battle against Dengue. Finally, Chapter 3 focuses on molecular dynamics simulations of a novel anti-HER2 Chimeric Antigen Receptor (CAR) for HER2-positive cancer treatment. The proposed Binding Induced Domain Dynamics Switch (BIDDS) unveils a new signal transduction mechanism, revolutionizing the understanding of CAR activation. This breakthrough not only challenges existing models but also opens avenues for broader applications in receptor-based therapies. These chapters collectively represent a multidisciplinary approach merging computational techniques, evolutionary biology, and molecular dynamics simulations, promising significant contributions to drug development, viral evolution understanding, and therapeutic advancements in cancer treatment."],"dc:identifier":["https://rdw.rowan.edu/etd/3202"],"dc:subject":["computer-aided drug design","viral evolution dynamics","molecular dynamics simulation","near-neutral balanced selectionist theory","anti-HER2 chimeric antigen receptor","HER-2 positive cancer treatment","Drugs-- Design","Cancer--Treatment","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"],"dc:title":["To decipher genomic evolution of dengue virus and to probe the activation mechanism of a HER2 directed chimeric antigen receptor toward computer aided drug design (CADD)"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (M.S.) in Pharmaceutical Science"]},"updated_at":"2026-11-19T08:59:40Z"}